Human Beta-migrating Very Low Density Lipoprotein Induces Foam Cell Formation in Human Mesangial Cells
Overview
Authors
Affiliations
To elucidate the mechanism of foam cell formation in the mesangial region of a kidney observed in a familial type III hyperlipoproteinemic patient presenting with diabetes mellitus and nephrotic syndrome, we have examined, in the present study, the effect of human beta-VLDL (apo E2/E2) on foam cell formation in human mesangial cells, since an increase in beta-VLDL is a characteristic feature of this patient. Human beta-VLDL (apo E2/E2) induced foam cell formation in human mesangial cells. The binding of [125I]LDL to human mesangial cells was inhibited completely by both LDL and beta-VLDL. On the other hand, the binding of [125I]beta-VLDL was completely inhibited by beta-VLDL, but partially by LDL. The LDL receptor, but not the VLDL receptor was down-regulated by accumulation of cholesteryl esters. These results suggest that human beta-VLDL (apo E2/E2)-induced foam cell formation in mesangial cells is mediated through both the LDL receptor pathway and the beta-VLDL specific pathway, in which the VLDL receptor is one of the candidates.
Cellular cholesterol transport proteins in diabetic nephropathy.
Tsun J, Yung S, Chau M, Shiu S, Chan T, Tan K PLoS One. 2014; 9(9):e105787.
PMID: 25181357 PMC: 4152117. DOI: 10.1371/journal.pone.0105787.
Rohde E, Schallmoser K, Reinisch A, Hofmann N, Pfeifer T, Frohlich E Cytotherapy. 2010; 13(4):503-12.
PMID: 21128706 PMC: 3173858. DOI: 10.3109/14653249.2010.536214.
Davis T, Ting R, Best J, Donoghoe M, Drury P, Sullivan D Diabetologia. 2010; 54(2):280-90.
PMID: 21052978 DOI: 10.1007/s00125-010-1951-1.